felin
immnunodefici
fiv
felin
leukemia
felv
virus
common
infecti
agent
stray
cat
shelter
environ
recombin
felin
interferonx
rfeifnx
shown
antivir
action
fiv
felv
also
herpesviru
caliciviru
fcv
sixteen
natur
infect
fivfelv
cat
follow
rfeifnx
therapi
order
monitor
clinic
sign
correl
excret
concomit
virus
fcv
felin
coronaviru
fcov
parvoviru
fpv
cat
submit
clinic
evalu
concomit
viru
excret
assess
compar
cat
improv
clinic
score
cat
posit
neg
reduc
viral
load
fcov
posit
cat
reduc
viral
load
fcv
posit
cat
fpv
posit
cat
neg
conclus
rfeifnx
improv
clinic
sign
reduc
concurr
viral
excret
natur
infect
retrovir
cat
felin
immunodefici
viru
fiv
felin
leukemia
viru
felv
two
import
retrovirus
infect
domest
cat
lutz
et
al
preval
differ
accord
geograph
region
indooroutdoor
statu
norri
et
al
common
risk
factor
geriatr
cat
male
gender
mix
breed
aggress
behavior
coinfect
retrovirus
outdoor
contact
nonhierarch
cat
commun
murray
et
al
even
sensit
diagnost
test
good
therapeut
approach
retrovirus
remain
problem
among
anim
rescu
shelter
lutz
et
al
clinic
sign
observ
cat
infect
retrovirus
nonspecif
mainli
due
immun
suppress
hartmann
felv
infect
cat
clinic
sign
usual
develop
viraem
anim
month
year
infect
fiv
infect
cat
clinic
sign
directli
caus
viraemia
result
secondari
infect
furthermor
fivinfect
cat
may
even
show
clinic
sign
result
imbalanc
stimul
part
immun
respons
immunemedi
glomerulonephr
although
mani
retrovir
infect
cat
go
develop
clinic
sign
other
may
remain
good
health
sever
year
immun
suppress
induc
retrovirus
may
predispos
cat
clinic
infect
multipl
opportunist
agent
would
normal
resist
moreov
also
possibl
trigger
exacerb
respons
common
bacteri
fungal
protozo
pathogen
occasion
dunham
graham
rech
et
al
rescu
cat
shelter
virus
felin
herpesviru
type
felin
caliciviru
fcv
felin
coronaviru
fcov
felin
parvoviru
fpv
also
import
infecti
agent
consid
particularli
exacerb
incom
anim
introduc
shelter
howev
even
stabl
resid
shelter
intermitt
excret
virus
may
contribut
continu
spread
environ
concurr
viral
infect
potenti
retrovir
infect
shelter
easili
contribut
gener
worsen
clinic
condit
infect
cat
radford
et
al
thiri
et
al
truyen
et
al
gener
manag
retrovir
infect
cat
includ
isol
polici
neuter
regular
health
checkup
particularli
rescu
shelter
symptomat
cat
support
gener
treatment
alway
consid
lutz
et
al
antivir
immun
modul
therapi
import
option
also
consid
collado
et
al
recogn
similar
fiv
human
immunodefici
viru
multipl
drug
zidovudin
fozivudin
human
interferona
commonli
use
human
appli
retrovir
infect
cat
howev
drug
signific
side
effect
domenech
et
al
fogl
et
al
interferon
famili
speciesspecif
compound
act
antivir
drug
also
immun
modul
antitumor
agent
gerlach
et
al
tompkin
classifi
type
type
ii
interferon
ifn
accord
biolog
properti
collado
et
al
pestka
et
al
type
ifn
produc
viral
infect
cell
immunomodul
effect
domenech
et
al
due
interact
specif
cellreceptor
concurr
induct
express
specif
gene
encod
cytokin
involv
innat
immun
moreov
type
ifn
also
antivir
effect
antiprolif
antiinflammatori
action
domenech
et
al
gerlach
et
al
gerlach
et
al
type
ii
ifn
mainli
immunomodulatori
low
level
antivir
effect
mean
less
use
clinic
practic
current
two
import
ifn
use
veterinari
medicin
human
interferona
recombin
felin
interferonx
rfeifnx
type
ifn
collado
et
al
although
proven
human
interferona
increas
surviv
time
fiv
felvcat
pedretti
et
al
weiss
et
al
develop
specif
neutral
antibodi
may
decreas
effici
muller
zeidner
et
al
recent
rfeifnx
licens
use
veterinari
medicin
name
treatment
canin
parvoviru
felin
retrovir
fiv
felv
infect
homolog
felin
molecul
good
safeti
index
induc
product
neutral
antibodi
de
mari
et
al
howev
despit
licens
limit
publish
inform
use
rfeifnx
retrovir
infect
initi
use
asymptomat
fiv
cat
describ
caney
et
al
first
conclus
result
provid
studi
reveal
clinic
improv
increas
surviv
time
felv
coinfect
symptomat
cat
de
mari
et
al
recent
studi
demonstr
rfeifnx
improv
clinic
condit
haematolog
paramet
felv
also
fiv
infect
cat
domenech
et
al
invivo
studi
support
expect
benefit
use
rfeifnx
extend
viral
infect
name
fcov
fcv
fpv
hennet
et
al
ishida
et
al
paltrinieri
et
al
ritz
et
al
thiri
et
al
studi
aim
evalu
role
rfeifnx
clinic
improv
natur
infect
fiv
felv
cat
live
rescu
shelter
clarifi
whether
therapi
also
reduc
concurr
viral
excret
fcv
fcov
fpv
sixteen
neuter
domest
shorthair
cat
male
femal
live
lisbon
anim
shelter
previous
determin
fiv
andor
felv
posit
statu
select
studi
nevertheless
inclus
cat
retest
confirm
fivfelv
infect
enzym
link
immunoabsorb
assay
virachekfiv
virachekfelv
synbiot
cat
live
good
condit
agreement
current
ethic
welfar
standard
procedur
involv
manipul
anim
consent
approv
committe
ethic
anim
welfar
faculti
veterinari
medicin
technic
univers
lisbon
cebea
also
clinic
direct
refer
anim
shelter
de
lisboa
take
account
anim
origin
unknown
age
past
inform
consid
irrelev
studi
nevertheless
anim
adult
age
estim
rang
year
old
anim
hous
two
differ
catteri
correl
fiv
felv
statu
due
previou
shelter
facil
coinfect
anim
hous
felv
catteri
subsequ
cat
divid
three
differ
group
accord
retrovir
statu
fiv
posit
cat
n
male
femal
felv
posit
cat
n
male
femal
coinfect
anim
n
male
femal
base
previou
studi
de
mari
et
al
inclus
criteria
follow
cat
age
breed
sex
heterogen
popul
cat
show
least
one
clinic
sign
potenti
relat
retrovir
infect
cat
previous
posit
rapid
immunemigr
fivfelv
test
result
exclus
criteria
cat
show
clinic
sign
malign
lymphoma
lymphoid
leukemia
cat
receiv
immunomodul
drug
corticotherapi
week
studi
cat
receiv
antibiot
nonsteroid
antiinflammatori
drug
week
studi
cat
complet
therapeut
protocol
vial
rfeifnx
virbagen
omega
virbac
reconstitut
accompani
salin
diluent
accord
manufactur
recommend
immedi
treatment
base
assumpt
deriv
two
previous
publish
doubl
arm
trial
rfeifnx
de
mari
et
al
domenech
et
al
singl
arm
studi
perform
anim
treat
rfeifnx
accord
licens
protocol
cycl
inject
day
treatment
cycl
consist
subcutan
inject
mukg
per
day
day
treatment
administ
two
veterinari
clinician
research
team
assess
therapi
design
report
consid
repres
stage
anim
treatment
despit
exclus
criteria
appli
anim
need
support
treatment
therapi
consequ
potenti
amoxicillin
hepat
protect
ursodeoxychol
acid
sylimarin
sadenilmethionin
andor
fluid
therapi
allow
antibiot
potenti
amoxicillin
corticosteroid
nonsteroid
antiinflammatori
drug
permit
avoid
possibl
immunomodul
effect
therapi
begin
protocol
cat
submit
regular
clinic
evalu
order
reduc
subject
find
clinic
evalu
score
accord
clinicalscor
scale
tabl
scale
includ
import
clinic
paramet
typic
present
retrovir
infect
fig
oral
ulcer
gingiv
score
caudal
stomatitispalat
score
ophthalm
abnorm
score
lymphadenopathi
score
ocular
nasal
discharg
score
mucou
membran
color
score
coat
appear
score
bodi
score
score
faecal
appear
score
concurr
diseasescomorbid
score
paramet
assess
sum
score
criteria
obtain
anim
reflect
overal
clinic
condit
anim
score
compar
time
point
blood
sampl
collect
venipunctur
jugular
vein
time
clinic
evalu
sampl
analys
complet
bloodcel
count
cbc
hepat
enzym
alaninetransaminas
aspartatetransaminas
renal
function
creatinin
urea
cbc
biochemistri
perform
celldyn
abbott
diagnost
divis
kone
optima
kemia
cientifica
respect
allow
better
evalu
simpler
blood
sampl
collect
cat
submit
mild
tranquil
mgkg
butorphanol
solut
dolorex
intervet
portug
subcutan
cat
group
check
fiv
antibodi
felv
antigen
elisa
use
serum
plasma
virachekfiv
virachekfelv
synbiot
time
point
oral
swab
felin
respiratori
tract
virus
fcv
rectal
swab
digest
tract
virus
fpv
fcov
also
obtain
oral
rectal
swab
process
viral
dnarna
extract
qiaamp
minelut
viru
spin
kit
qiagen
portug
determin
quantif
concurr
viral
excret
perform
use
diagnost
procedur
avail
virolog
laboratori
faculti
veterinari
medicin
technic
univers
lisbon
screen
quantif
assess
real
time
polymeras
chain
reaction
pcr
amplif
appli
instrument
appli
biosystem
use
specif
gene
express
kit
taqman
gene
express
kit
appli
biosystem
primer
cycl
condit
describ
tabl
serial
tenfold
dilut
recombin
plasmid
dna
use
estim
target
copi
number
use
specif
softwar
system
sd
softwar
gener
standard
curv
obtain
dna
dilut
recombin
plasmid
correl
effici
r
fcv
presenc
assess
use
convent
revers
transcriptas
pcr
desario
et
al
wilhelm
truyen
use
ng
viral
rna
primer
cycl
condit
describ
tabl
live
vaccin
fevaxyn
pentofel
pfizer
use
posit
control
fpv
presenc
assess
use
convent
pcr
desario
et
al
wilhelm
truyen
ten
ng
viral
dna
use
amplifi
sequenc
within
gene
primer
cycl
condit
describ
tabl
screen
quantif
fcov
primer
probe
taqman
appli
biosystem
chosen
use
specif
softwar
primer
express
appli
biosystem
within
bp
fragment
includ
utr
region
fcov
herrewegh
et
al
previous
clone
pgem
plasmid
duart
et
al
fcov
quantif
assess
one
step
realtim
pcr
taqman
kit
appli
biosystem
use
cycl
condit
describ
tabl
serial
tenfold
dilut
recombin
plasmid
dna
use
estim
fcov
target
copi
number
use
refer
specif
softwar
h
gener
standard
curv
correl
effici
r
compar
clinic
score
viral
load
differ
treatment
day
non
parametr
friedman
test
appli
signific
level
set
remain
analys
mean
valu
respect
standard
error
report
cat
submit
clinic
evalu
start
therapi
rfeifnx
use
score
scale
tabl
oral
ulcer
gingiv
frequent
clinic
sign
group
caudal
stomat
also
preval
find
begin
studi
particularli
fiv
posit
cat
also
clinic
sign
improv
consist
therapi
concern
paramet
variabl
therapi
nonspecif
fluctuat
observ
detail
individu
clinic
score
record
tabl
consid
total
valu
clinic
score
cours
studi
fiv
coinfect
cat
improv
homogen
therapi
convers
felv
cat
show
import
fluctuat
therapi
mean
cat
mean
score
worsen
despit
result
compar
total
score
global
improv
observ
compar
begin
end
treatment
respect
overal
improv
clinic
score
indic
better
clinic
condit
natur
retrovir
infect
cat
statist
signific
p
friedman
test
particular
cat
improv
clinic
condit
cat
maintain
clinic
statu
cat
experienc
worsen
score
regard
fiv
group
clinic
improv
also
statist
signific
p
friedman
test
particular
cat
show
mark
improv
final
score
better
initi
reveal
mild
moder
improv
final
score
better
initi
remain
stabl
concern
felv
infect
cat
clinic
improv
statist
relev
p
friedman
test
nevertheless
observ
show
mild
moder
improv
remain
initi
score
two
three
coinfect
cat
show
mark
improv
one
three
remain
stabl
howev
due
low
number
anim
group
result
statist
signific
p
friedman
test
although
mild
fluctuat
observ
hematolog
paramet
remain
within
refer
rang
therapi
one
fiv
posit
cat
develop
mild
anemia
clinic
irrelev
one
felv
posit
cat
reveal
moder
anemia
also
mean
valu
redblood
cell
concentr
standard
error
shown
fig
despit
irrelev
occasion
variat
anim
normal
leucocyt
level
therapi
mean
valu
display
fig
cat
renal
paramet
liver
enzym
remain
stabl
within
refer
rang
therapi
oral
swab
fcv
detect
process
viral
rna
describ
amplif
show
preval
fcv
shed
fiv
felv
fig
coinfect
fiv
felv
coinfect
cat
test
neg
fiv
cat
test
posit
fcv
gingivostomat
contrast
felv
coinfect
group
fcv
posit
anim
show
clinic
sign
previous
describ
oral
swab
process
viral
dna
extract
quantif
reveal
posit
cat
fiv
felv
coinfect
detail
result
summar
fig
compar
fiv
infect
cat
reduc
excret
cat
test
neg
fig
also
group
one
cat
show
punctual
excret
test
neg
felv
group
posit
cat
test
neg
two
still
excret
although
lower
level
fig
also
group
cat
reveal
punctual
excret
one
reduc
test
neg
coinfect
cat
cat
posit
cat
still
excret
lower
level
cat
test
neg
fig
compar
overal
reduct
excret
statist
signific
natur
retrovir
infect
cat
p
friedman
test
correl
viral
statu
individu
clinic
score
observ
cat
confid
interv
show
concurr
clinic
improv
reduct
excret
rectal
swab
use
screen
quantif
fcov
show
posit
fiv
felv
coinfect
nine
decreas
viral
excret
detail
fiv
infect
cat
reduc
fcov
viral
excret
cat
increas
fig
felv
group
compar
fcov
infect
cat
reduc
viral
load
enhanc
two
cat
neg
reveal
punctual
excret
decreas
zero
valu
near
zero
coinfect
cat
fcov
posit
reduc
viral
excret
interestingli
one
coinfect
cat
neg
fcov
excret
reveal
increas
excret
reduc
fig
compar
overal
group
result
statist
signific
p
friedman
test
correl
fcov
excret
individu
clinic
score
observ
cat
confid
interv
show
concurr
clinic
improv
reduct
fcov
excret
rectal
swab
also
use
fpv
screen
one
felv
infect
cat
test
posit
convent
pcr
parvoviru
excret
till
end
therapi
cat
remain
neg
fivfelv
natur
infect
cat
follow
rfeifnx
treatment
paramet
clinic
evalu
haematolog
analysi
viral
load
assess
individu
cat
therapi
assess
de
tabl
total
group
detail
individu
clinic
score
valu
paramet
evalu
fiv
cat
rfeifnx
therapi
oral
ulcer
ignat
repres
stage
anim
therapi
rfeifnx
licens
product
efficaci
describ
multipl
doubl
arm
studi
de
mari
et
al
domenech
et
al
singl
arm
trial
perform
order
extend
understand
improv
retrovir
infect
cat
therapi
control
result
group
without
treatment
placebo
consid
limit
interest
ethic
controversi
context
control
group
would
eventu
import
studi
experiment
infect
anim
cat
stage
infect
case
heterogen
group
cat
difficult
know
point
stage
infect
even
cat
locat
shelter
environ
inclus
placebo
group
even
controversi
ethic
inde
whole
point
therapi
shelter
environ
believ
studi
reflect
crude
realiti
cat
shelter
sens
decis
establish
control
group
therapi
deliber
assum
viewpoint
measur
shelter
environ
potenti
repres
placebo
differ
stage
infect
group
therefor
cat
day
consid
best
untreat
control
regard
length
studi
would
also
interest
evalu
viral
excret
week
end
therapi
howev
inclus
new
anim
catteri
could
exclud
timepoint
imposs
consid
reliabl
followup
group
viral
excret
reinfect
could
occur
therefor
although
anim
follow
timepoint
sampl
collect
viral
excret
conclud
time
point
accord
previou
studi
domenech
et
al
clinic
condit
major
cat
improv
rfeifnx
treatment
improv
pronounc
cat
higher
initi
clinic
score
cat
mildli
symptomat
start
studi
remain
stabl
cat
got
wors
end
studi
start
compar
felv
cat
fiv
cat
present
evid
gener
improv
fluctuat
observ
felv
cat
cours
studi
contribut
worsen
clinic
score
interim
time
point
certain
cat
recogn
rfeifnx
immunemodul
possibl
explan
refer
fact
felv
cat
compromis
immun
respons
comparison
fiv
cat
pardi
et
al
mainli
due
fact
felv
infect
cat
seem
pronounc
defect
helper
tcell
consequ
anim
reduc
humor
immun
respons
tabl
despit
low
number
anim
coinfect
group
also
show
good
improv
compar
felv
cat
anim
rfeifnx
also
seem
import
imunomodulatori
effect
result
signific
improv
evid
clinic
sign
inclus
group
oral
ulcer
gingivitisgingivostomat
improv
rfeifnx
therapi
although
condit
multifactori
etiolog
rfeifnx
well
known
prescrib
therapi
felin
chronic
gingivostomatit
syndrom
fcg
dower
et
al
result
corrobor
relev
use
howev
interest
note
previous
publish
studi
use
rfeifnx
manag
fcg
focus
retroviru
neg
cat
hennet
et
al
first
time
knowledg
evid
present
efficaci
felv
fiv
posit
cat
previou
studi
suggest
rfeifnx
effect
retrovirusinduc
anemia
cat
de
mari
et
al
improv
haematolog
profil
domenech
et
al
studi
cat
normal
haematolog
valu
consequ
signific
chang
observ
therapi
even
felv
cat
often
lymphopen
normal
baselin
show
relev
chang
treatment
two
cat
fiv
felv
develop
anaemia
nevertheless
cat
close
monitor
end
studi
two
week
later
cbc
repeat
show
normal
valu
suggest
temporari
irrelev
fluctuat
valu
renal
function
transaminas
also
assess
cat
normal
biochemistri
profil
significantli
chang
therapi
accord
european
medi
cine
agenc
publish
scientif
discuss
rfeifnx
may
lead
temporari
leucopenia
thrombocytopenia
anaemia
increas
alanin
aminotransferas
mild
shortterm
anaemia
sporad
clinic
irrelev
trombocytopenia
none
sideeffect
observ
one
main
goal
studi
evalu
concurr
viral
excret
cat
rfeifnx
therapi
author
suggest
fivposit
cat
coinfect
virus
fcv
andor
felv
seem
higher
preval
oral
infect
sever
oral
lesion
tenorio
et
al
agre
present
result
studi
fact
fiv
cat
test
posit
fcv
gingivostomat
felv
group
fcv
posit
cat
sever
gingivostomat
mild
gingiv
observ
oral
lesion
coinfect
cat
anim
test
fcv
posit
oral
sign
fcv
statu
also
associ
extens
gingiv
palat
mucosa
later
palatogloss
arch
caudal
stomatitispalat
three
four
fivfcv
posit
cat
present
sign
even
low
sampl
size
find
agre
previou
studi
report
greater
proport
cat
caudal
stomat
fcv
posit
hennet
boucrautbaralon
contrast
felv
coinfect
anim
one
cat
group
present
caudal
stomat
recent
studi
describ
use
rfeifnx
oral
administr
refractori
case
caudal
stomat
hennet
et
al
author
knowledg
studi
describ
use
rfeifnx
licens
protocol
concurr
retrovir
fcvinfect
cat
anim
posit
fcv
fiv
felv
coinfect
cat
test
neg
fcv
mean
rfeifnx
administ
accord
protocol
associ
remiss
fcv
excret
cat
furthermor
cat
reveal
persist
oral
lesion
end
therapi
remain
fcv
posit
anim
improv
gingivostomat
palat
although
fcg
may
multifactori
etiolog
improv
oral
clinic
sign
evid
agre
observ
reduct
fcv
excret
like
observ
improv
clinic
sign
shed
fcv
due
combin
immunomodul
antivir
effect
treatment
especi
import
anim
shelter
gingivostomat
frequent
associ
activ
fcv
infect
anim
may
also
like
experi
stressinduc
reduct
immun
compet
recogn
ubiquit
catteri
preval
among
retrovir
infect
cat
expect
elev
anim
test
posit
rfeifnx
therapi
reduct
excret
observ
p
friedman
test
curious
shed
even
complet
suppress
anim
therapi
typic
respiratori
ocular
sign
remark
shelter
cat
howev
concurr
clinic
improv
reduct
excret
observ
cat
lead
conclud
particular
case
reduct
shed
may
contribut
clinic
improv
despit
good
clinic
find
anim
shelter
may
remain
latent
suppress
viral
excret
may
lead
complet
cure
dower
et
al
also
anim
effect
may
temporari
therefor
clinic
followup
also
reduct
inputoutput
anim
within
catteri
consid
report
felin
popul
catteri
fcov
posit
expect
studi
cat
test
posit
infect
cat
may
shed
high
viral
load
fcov
without
show
relev
symptom
foley
et
al
meli
et
al
despit
promis
result
initi
studi
use
rfeifnx
therapi
cat
clinic
felin
infecti
periton
ishida
et
al
one
abl
reveal
signific
clinic
improv
ritz
et
al
howev
viral
excret
assess
knowledg
first
studi
describ
effect
rfeifnx
fcov
excret
level
natur
fiv
felv
infect
cat
despit
fluctuat
explain
non
statist
signific
result
p
friedman
test
viral
excret
decreas
anim
posit
fcov
cat
show
rfeifnx
therapi
seem
help
situat
remark
sever
cat
show
concurr
clinic
improv
reduct
fcov
excret
therefor
fcov
statu
may
also
contribut
better
clinic
condit
observ
case
fcov
also
viral
excret
continu
process
fluctuat
observ
fact
cat
show
punctual
excret
virus
name
possibl
explan
may
resid
licens
rfeifnx
protocol
worth
note
followup
time
point
studi
anim
experienc
rfeifnx
administr
previou
day
fpv
screen
one
cat
test
posit
convent
pcr
neg
day
treatment
fact
parvoviru
pcr
detect
speciesspecif
recent
report
clegg
et
al
healthi
cat
may
shed
canin
parvoviru
import
reservoir
viru
name
anim
shelter
due
lack
clinic
sign
agreement
studi
cat
assum
subclin
carrier
studi
correspond
common
realiti
anim
shelter
overflow
cat
continu
resid
rotat
stray
anim
introduc
other
adopt
may
contribut
potenti
differ
ubiquit
viral
infect
concern
result
rfeifnx
seem
abl
contribut
manag
realiti
improv
clinic
sign
decreas
concurr
viral
excret
summari
rfeifnx
therapi
may
benefici
natur
retrovir
infect
cat
particularli
shelterrescu
context
preval
concomit
infect
higher
